CLL Treatment: State-of-the-art
Session III of ERIC 2018 meeting featured experts Jacqueline Barrientos, MD, and William Wierda, MD, PhD, presenting on the potential pathways for inhibition and whether combining treatment modalities are actually useful or not.
Feinstein Institute for Medical Research, Manhasset, NY
Jacqueline Barrientos, MD, from Feinstein Institute for Medical Research, Manhasset, NY, discusses pathway inhibitors for CLL therapy.
MD Anderson Cancer Center, Houston, TX
William Wierda, MD, PhD, from MD Anderson Cancer Center, Houston, TX, talks about combining treatment modalities.